October 13, 2024

The Targeted Pulse: Uncover Essential Developments in Breast Cancer, Multiple Myeloma, and NSCLC Treatment and the Latest FDA Approvals – Targeted Oncology

October 10, 2024

EU Approval Sought for D-VRd in Newly Diagnosed Myeloma – OncLive

October 10, 2024

Functional High Risk and Bridging in Multiple Myeloma Considered With CAR T Cells – Targeted Oncology

October 10, 2024

Johnson & Johnson myeloma drug recommended for NHS use – PharmaTimes

October 9, 2024

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

New England Journal of Medicine, Volume 391, Issue 14, Page 1364-1365, October 10, 2024.